Booster dose
Omicron-specific vaccines: can be helpful, but needs a global policy, experts opine
Ever since Moderna and Pfizer-BioNTech have started the variant-specific vaccine’s clinical trials, the international community of researchers and scientists are arguing about the necessity, need or sustainability of such variant-specific vaccines
